Evicenter
P&T meetings

Ivonescimab

EGFR-mutated non-small-cell lung cancer

Launch
Not announced
Last updated
79 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatment

Heterogeneity of treatment effect

2 evidence topics · 3 sources

Summary

The geographically stratified survival update and individual case reports describe possible variation in treatment outcomes. The case reports do not establish comparative treatment effects or validate predictive biomarkers. The reported geographic HRs should not be interpreted as proof that treatment effects are identical across regions.